Active-ingredient Dossier
Brinzolamide
Active-ingredient Dossier for Brinzolamide (carbonic anhydrase inhibitor). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: AZOPT
- Brand: AZARGA
- Brand: BRINZOQUIN
- Brand: SIMBRINZA
- Therapeutic area: Ophthalmology
What is
Brinzolamide Brinzolamide is a carbonic anhydrase inhibitor.
Australian brands containing
Brinzolamide — AZOPT — AZARGA — BRINZOQUIN — SIMBRINZA
Therapeutic areas
Brinzolamide is registered in ophthalmology, with four brands available in this therapeutic area.
Sponsor landscape
Novartis Pharmaceuticals markets brinzolamide in Australia.
PBS and regulatory activity
One brand containing brinzolamide has PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome on record is 1 July 2015.